Montalbano, John — Insider Profile

Insider Profile

Montalbano, John

🔒 Follow — get an alert on any new filing

$EPRX $MFC

Companies Filed At

Open-Market Buys (2yr)

$520K

Buy Value (2yr, open-market)

Aug 19, 2026

Most Recent Trade

Credibility
Score

67%

Hit Rate

+10.8%

Avg 90d Return

+16.9%

Median 90d Return

Evaluated Trades

+16.9%

Best Trade

-1.3%

Worst Trade

Hit rate and returns are based on 3 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days

$EPRX 73

Eupraxia Pharmaceuticals

$150K · 1 buy

Last buy Aug 19, 2026

Political Donations · Elections Canada

$5K in individual political contributions across 4 donations (2014–2014).

Date	Party	Recipient	Amount
2014-09-09	Liberal Party of Canada	Garneau, Marc	$1K
2014-09-09	Liberal Party of Canada	Liberal Party of Canada	$1K
2014-08-28	Liberal Party of Canada	Liberal Party of Canada	$1K
2014-08-28	Liberal Party of Canada	Vancouver Granville Federal Liberal Association	$1K

Source: Elections Canada public contribution records (individual donations only; corporate political donations have been banned federally since 2007). Matched to this insider by name — shown for transparency, not a claim of wrongdoing and not a Confluence Score input.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Aug 19, 2026	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	22,000	$6.82	$150K	73
Jun 30, 2026	$MFC Manulife Financial	—	Plan / DRIP	Buy	37	—	—	34
Jun 30, 2026	$MFC Manulife Financial	—	Other	Buy	844	—	—	34
Mar 31, 2026	$MFC Manulife Financial	—	Other	Buy	1,021	—	—	34
Mar 31, 2026	$MFC Manulife Financial	—	Plan / DRIP	Buy	34	—	—	34
Mar 09, 2026	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	21,875	$11.20	$245K	73
Feb 02, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	243,900	$3.00	$732K	73
Feb 02, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	243,900	$3.00	$732K	73
Dec 31, 2025	$MFC Manulife Financial	—	Other	Buy	871	—	—	34
Dec 31, 2025	$MFC Manulife Financial	—	Plan / DRIP	Buy	21	—	—	34
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	10,000	$8.63	$86K	73
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	10,000	$8.63	$86K	73
Nov 02, 2025	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	12,500	$8.00	$100K	73
Sep 30, 2025	$MFC Manulife Financial	—	Plan / DRIP	Buy	14	—	—	34
Sep 30, 2025	$MFC Manulife Financial	—	Other	Buy	1,029	—	—	34
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	67,273	$5.50	$370K	73
Mar 31, 2025	$MFC Manulife Financial	—	Other	Buy	357	—	—	34
Mar 31, 2025	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	25,000	$8.00	$200K	73
Mar 25, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	45,000	$5.14	$231K	73
Feb 28, 2025	$MFC Manulife Financial	—	Other	Sell	—	—	—	34
Feb 28, 2025	$MFC Manulife Financial	—	Other	Sell	—	—	—	34
Jun 28, 2024	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	14,800	$3.50	$52K	73
May 13, 2024	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	45,000	$3.96	$178K	73
Jan 04, 2024	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	39,846	$7.20	$287K	73
Aug 18, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Sell	75,000	$7.00	$525K	73
Dec 16, 2022	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	22,006	$8.00	$176K	73
Sep 07, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	4,500	$1.50	$7K	73
Sep 06, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	1,600	$1.50	$2K	73
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	43,750	$8.00	$350K	73
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	21,875	$0.00	$44	73
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Corp. Event	Buy	122,595	$8.00	$981K	73
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	37,500	$8.00	$300K	73

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.